• Issue

    Liver International: Volume 41, Issue 11

    2529-2810
    November 2021
Previous Issue|Next Issue
Export Citation(s)Download PDF(s)

ISSUE INFORMATION

Free Access

Issue Information

  • Pages: 2529-2533
  • First Published: 18 October 2021

REVIEWS & META-ANALYSES

Free Access

Zonation in NASH – A key paradigm for understanding pathophysiology and clinical outcomes

Jonathan B. Steinman,  Marcela A. Salomao,  Utpal B. Pajvani, 
  • Pages: 2534-2546
  • First Published: 30 July 2021
Open Access

How to get away with liver innate immunity? A viruses’ tale

Marion Delphin,  Manon Desmares,  Svenja Schuehle,  Mathias Heikenwalder,  David Durantel,  Suzanne Faure-Dupuy, 
  • Pages: 2547-2559
  • First Published: 14 September 2021
Free Access

COVID-19, adaptative immune response and metabolic-associated liver disease

Luca Miele,  Cecilia Napodano,  Alfredo Cesario,  Antonio De Magistris,  Krizia Pocino,  Umberto Basile,  Gian L. Rapaccini,  Antonio Gasbarrini,  Antonio Grieco, 
  • Pages: 2560-2577
  • First Published: 23 September 2021

LIVER DISEASE AND PUBLIC HEALTH

Open Access

Outcomes of the CT2 study: A ‘one-stop-shop’ for community-based hepatitis C testing and treatment in Yangon, Myanmar

Bridget Louise Draper,  Hla Htay,  Alisa Pedrana,  Win Lei Yee,  Jessica Howell,  Khin Pyone Kyi,  Win Naing,  Khin Sanda Aung,  Jessica Markby,  Philippa Easterbrook,  Anna Bowring,  Win Aung,  Yi Yi Sein,  Nwe Nwe,  Kyi Thar Myint,  Sonjelle Shilton,  Margaret Hellard, 
  • Pages: 2578-2589
  • First Published: 21 June 2021
Open Access

Incidence of liver-related morbidity and mortality in a population cohort of non-alcoholic fatty liver disease

Ville T. Männistö,  Veikko Salomaa,  Martti Färkkilä,  Antti Jula,  Satu Männistö,  Iris Erlund,  Jouko Sundvall,  Annamari Lundqvist,  Markus Perola,  Fredrik Åberg, 
  • Pages: 2590-2600
  • First Published: 05 July 2021

VIRAL HEPATITIS

Inferior cure rate in pilot study of 4-week glecaprevir/pibrentasvir treatment with or without ribavirin of chronic hepatitis C

Lone W. Madsen,  Peer B. Christensen,  Ulrik Fahnøe,  Martin S. Pedersen,  Jens Bukh,  Anne Øvrehus, 
  • Pages: 2601-2610
  • First Published: 21 June 2021
Open Access

Peripheral neuropathy after viral eradication with direct-acting antivirals in chronic HCV hepatitis: A prospective study

Maria M. Zanone,  Claudia Marinucci,  Alessia Ciancio,  Dario Cocito,  Federica Zardo,  Emanuela Spagone,  Bruno Ferrero,  Cristina Cerruti,  Lorena Charrier,  Franco Cavallo,  Giorgio M. Saracco,  Massimo Porta, 
  • Pages: 2611-2621
  • First Published: 05 July 2021
Open Access

Epidemiological trends of HBV and HDV coinfection among Viennese HIV+ patients

Caroline Schmidbauer,  David Chromy,  Victor U. Schmidbauer,  Michael Schwarz,  Mathias Jachs,  David J. M. Bauer,  Teresa Binter,  Michael Apata,  Dung T. Nguyen,  Mattias Mandorfer,  Benedikt Simbrunner,  Armin Rieger,  Florian Mayer,  Monika Breuer,  Robert Strassl,  Ralf Schmidt,  Heidemarie Holzmann,  Michael Trauner,  Michael Gschwantler,  Thomas Reiberger, 
  • Pages: 2622-2634
  • First Published: 16 July 2021

METABOLIC & TOXIC LIVER DISEASES

Ultra-processed food is associated with features of metabolic syndrome and non-alcoholic fatty liver disease

Dana Ivancovsky-Wajcman,  Naomi Fliss-Isakov,  Muriel Webb,  Itay Bentov,  Oren Shibolet,  Revital Kariv,  Shira Zelber-Sagi, 
  • Pages: 2635-2645
  • First Published: 26 June 2021
Open Access

Anti-TNFα treatment in Crohn’s disease: Impact on hepatic steatosis, gut-derived hormones and metabolic status

Paul Manka,  Svenja Sydor,  Nishikant Wase,  Jan Best,  Malte Brandenburg,  Annika Hellbeck,  Julia Schänzer,  Ramiro Vilchez-Vargas,  Alexander Link,  Anja Figge,  Andreas Jähnert,  Ulrike von Arnim,  Jason D. Coombes,  Francisco-Javier Cubero,  Alisan Kahraman,  Moon-Sung Kim,  Julia Kälsch,  Sonja Kinner,  Klaas-Nico Faber,  Han Moshage,  Guido Gerken,  Wing-Kin Syn,  Scott L. Friedman,  Ali Canbay,  Lars P. Bechmann, 
  • Pages: 2646-2658
  • First Published: 05 July 2021
Open Access

PPAR-γ-induced changes in visceral fat and adiponectin levels are associated with improvement of steatohepatitis in patients with NASH

Amalia Gastaldelli,  Silvia Sabatini,  Fabrizia Carli,  Melania Gaggini,  Fernando Bril,  Renata Belfort-DeAguiar,  Vincenzo Positano,  Diana Barb,  Sushma Kadiyala,  Stephen Harrison,  Kenneth Cusi, 
  • Pages: 2659-2670
  • First Published: 05 July 2021

Drug-induced liver injury associated with severe cutaneous adverse drug reactions: A nationwide study in Taiwan

Yi-Shin Huang,  Chen-Yi Wu,  Ting-Tsung Chang,  Cheng-Yuan Peng,  Gin-Ho Lo,  Chao-Wei Hsu,  Chi-Tan Hu,  Yi-Hsiang Huang, 
  • Pages: 2671-2680
  • First Published: 21 June 2021

GUT-LIVER AXIS, IMMUNOLOGY, IMMUNE MEDIATED AND CHOLESTATIC DISEASES

Collagen proportionate area correlates with histological stage and predicts clinical events in primary sclerosing cholangitis

Francesca Saffioti,  Andrew Hall,  Manon de Krijger,  Joanne Verheij,  Stefan G. Hübscher,  James Maurice,  Tu Vinh Luong,  Massimo Pinzani,  Cyriel Y. Ponsioen,  Douglas Thorburn, 
  • Pages: 2681-2692
  • First Published: 29 May 2021
Open Access

High prevalence of celiac disease in autoimmune hepatitis: Systematic review and meta-analysis

Linnea Haggård,  Ida Glimberg,  Benjamin Lebwohl,  Rajani Sharma,  Elizabeth C. Verna,  Peter H. R. Green,  Jonas F. Ludvigsson, 
  • Pages: 2693-2702
  • First Published: 05 July 2021

Racial differences in primary sclerosing cholangitis mortality is associated with community socioeconomic status

Vijay S. Are,  Eduardo Vilar- Gomez,  Mark A. Gromski,  Fatih Akisik,  Craig Lammert,  Marwan Ghabril,  Naga Chalasani,  Raj Vuppalanchi,  Lauren D. Nephew, 
  • Pages: 2703-2711
  • First Published: 09 July 2021

GENETICS AND RARE LIVER DISEASES

NR1H4 rs35724 G>C variant modulates liver damage in nonalcoholic fatty liver disease

Stefania Grimaudo,  Paola Dongiovanni,  Jussi Pihlajamäki,  Mohammed Eslam,  Hannele Yki-Järvinen,  Rosaria Maria Pipitone,  Guido Baselli,  Calogero Cammà,  Vito Di Marco,  Marco Enea,  Miriam Longo,  Grazia Pennisi,  Daniele Prati,  Rossella Zito,  Anna Ludovica Fracanzani,  Antonio Craxì,  Jacob George,  Stefano Romeo,  Luca Valenti,  Salvatore Petta, 
  • Pages: 2712-2719
  • First Published: 16 July 2021
Open Access

Clinical characterization of NTCP deficiency in paediatric patients : A case-control study based on SLC10A1 genotyping analysis

Li-Jing Deng,  Wen-Xian Ouyang,  Rui Liu,  Mei Deng,  Jian-Wu Qiu,  Muhammad-Rauf Yaqub,  Muhammad-Atif Raza,  Wei-Xia Lin,  Li Guo,  Hua Li,  Feng-Ping Chen,  Ying Ouyang,  Yu-Ge Huang,  Yue-Jun Huang,  Xiao-Ling Long,  Xiao-Ling Huang,  Shuang-Jie Li,  Yuan-Zong Song, 
  • Pages: 2720-2728
  • First Published: 09 August 2021

CIRRHOSIS, LIVER FAILURE AND TRANSPLANTATION

Sequential changes in urinary biomarker levels in patients with cirrhosis and severe hepatorenal syndrome

Cristina Solé,  Ann T. Ma,  Elsa Solà,  Marta Carol,  Núria Fabrellas,  Adrià Juanola,  Laura Napoleone,  Jordi Gratacós-Ginès,  Octavi Bassegoda,  Marta Cervera,  Martina Pérez,  Ana Belén Rubio,  Emma Avitabile,  Manuel Morales-Ruiz,  Isabel Graupera,  Elisa Pose,  Patrick S. Kamath,  Pere Ginès, 
  • Pages: 2729-2732
  • First Published: 27 September 2021
Open Access

Elastography is unable to exclude cirrhosis after sustained virological response in HCV-infected patients with advanced chronic liver disease

Teresa Broquetas,  Paula Herruzo-Pino,  Zoe Mariño,  Dolores Naranjo,  Mercedes Vergara,  Rosa Mª Morillas,  Xavier Forns,  José A. Carrión, 
  • Pages: 2733-2746
  • First Published: 15 September 2021

A population-based study of pyogenic liver abscess in Korea: Incidence, mortality and temporal trends during 2007-2017

Jeong-Ju Yoo,  Tae Kyu Lee,  Dae-Sung Kyoung,  Min-Ae Park,  Sang Gyune Kim,  Young Seok Kim, 
  • Pages: 2747-2758
  • First Published: 15 August 2021

LIVER CANCER

Open Access

Ramucirumab in patients with previously treated advanced hepatocellular carcinoma: Impact of liver disease aetiology

Peter R. Galle,  Masatoshi Kudo,  Josep M. Llovet,  Richard S. Finn,  Mark Karwal,  Denis Pezet,  Tae-You Kim,  Tsai-Sheng Yang,  Sara Lonardi,  Jiri Tomasek,  Jean-Marc Phelip,  Yann Touchefeu,  Su-Jin Koh,  Guido Stirnimann,  Kun Liang,  Kenyon D. Ogburn,  Chunxiao Wang,  Paolo Abada,  Ryan C. Widau,  Andrew X. Zhu, 
  • Pages: 2759-2767
  • First Published: 26 June 2021

Development of a simple dynamic algorithm for individualized hepatocellular carcinoma risk-based surveillance using pre- and post-treatment general evaluation score

Gamal Shiha,  Reham Soliman,  Nabiel Mikhail,  Ayman Hassan,  Mohammed Eslam, 
  • Pages: 2768-2776
  • First Published: 26 June 2021

Association of aspirin and statin use with the risk of liver cancer in chronic hepatitis B: A nationwide population-based study

Won-Mook Choi,  Hyo Jeong Kim,  Ae Jeong Jo,  So Hyun Choi,  Seungbong Han,  Min Jung Ko,  Young-Suk Lim, 
  • Pages: 2777-2785
  • First Published: 09 July 2021

LIVER INTERNATIONAL IMAGES

Open Access

One liver, two samples and two diagnoses—An example of how multiple samples by laparoscopically guided liver biopsy can be decisive

Claudia Beisel,  Sören A. Weidemann,  Marcial Sebode, 
  • Pages: 2786-2787
  • First Published: 29 September 2021

EXPERIMENTAL HEPATOLOGY

TPRG1-AS1 induces RBM24 expression and inhibits liver cancer progression by sponging miR-4691-5p and miR-3659

Ji-Hye Choi,  So M. Kwon,  Sung U. Moon,  Sarah Yoon,  Masaud Shah,  Byoung G. Lee,  Jieun Yang,  Young N. Park,  Hee-Jung Wang,  Hyun G. Woo, 
  • Pages: 2788-2800
  • First Published: 30 July 2021

RESEARCH LETTERS

PNPLA3 and COVID-19 outcomes: Thinking outside the box might explain the biology behind pleiotropic effects of rs738409 on the immune system

Carlos J. Pirola,  Silvia Sookoian, 
  • Pages: 2801-2804
  • First Published: 29 August 2021
Open Access

Gulf Cooperation Council states: On the brink of HBV elimination

Jeffrey V. Lazarus,  Henry E. Mark,  Faisal M. Sanai,  Almoutaz Hashim,  Mohamed Farghaly,  Saleh A. Alqahtani,  Sameer Al-Awadhi, 
  • Pages: 2805-2808
  • First Published: 25 September 2021

LETTER TO THE EDITOR

Aspartate aminotransferase in COVID-19: A probably overrated marker

Elena Aloisio,  Mauro Panteghini, 
  • Pages: 2809-2810
  • First Published: 05 October 2021